Developed and evaluated by Atlantis Health New Zealand, the myMeds program for people living with type 2 diabetes demonstrates improved medication adherence, with program members reporting high satisfaction and positive health impact. Results were presented at the June 2021 virtual conference of the International Congress of Behavioral Medicine.
A summary case study is available here
Delivering Improved Outcomes in Type 2 Diabetes With Personalized Support
Tuesday, June 15, 2021